AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Iradimed Co (NASDAQ:IRMD)
59.68 USD
+0.360 0.607%Sponsored Reports
Loading...
| Previous Close (in USD) | 59.32 |
|---|---|
| Change | +0.360 0.607% |
| 52 W H/L (in USD) | 50.153/35.494 |
| EBITDA (in USD) | 21.585M |
| PE Ratio | 30.36 |
| Volume | 24121 |
| Diluted Eps TTM | 1.40 |
| Total Assets (in USD) | 92.156M |
|---|---|
| Total Liabilities (in USD) | 20.736M |
| Revenue TTM (in USD) | 67.685M |
| Cash (in USD) | 49.762M |
| Market Cap (in USD) | 538.355 M |
| Revenue Per Share TTM | 5.363 |
| Gross Profit TTM (in USD) | 41.282M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
1025 Willa Springs Drive, Winter Springs, FL, United States, 32708
407 677 8022
Employees: 148
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Roger E. Susi | Founder, Chairman, CEO & Pres | 1953 |
| 2. | Mr. Randy Waddell | VP of Worldwide Sales & Marketing | NA |
| 3. | Mr. John F. Glenn | Chief Financial Officer | 1962 |
| 4. | Mr. Chris Williamson | Exec. VP of Continuous Improvement & Information Technology | NA |
| 5. | Mr. Matt Garner | Controller | NA |
| 6. | Mr. Roger E. Susi | Founder, Chairman, CEO & President | 1953 |
| 7. | Mr. John F. Glenn | CFO & Corporate Secretary | 1962 |
| 8. | Mr. Randy Waddell | Vice President of Worldwide Sales & Marketing | NA |
| 9. | Mr. Steve Kachelmeyer | Vice President of Regulatory Affairs & Quality Assurance | NA |
| 10. | Mr. Lynn Neuhardt | Vice President of Research & Development | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
-0.250 0.188% | 133.47 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
|
SYK
Stryker Corporation |
+1.300 0.334% | 390.345 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+0.325 0.367% | 88.83 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+0.460 0.449% | 102.95 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | 16.181M | 9.836M | -0.617M | 9.043M | 6.197M |
| Minority Interest | - | - | - | - | - |
| Net Income | 12.827M | 9.325M | 1.369M | 9.631M | 6.303M |
| Selling General Administrative | 10.697M | 9.771M | 12.269M | 10.451M | 8.711M |
| Gross Profit | 41.282M | 32.05M | 23.574M | 29.701M | 23.227M |
| Reconciled Depreciation | 0.671M | 1.407M | 1.339M | 1.242M | 1.105M |
| Ebit | 14.957M | 9.818M | -0.756M | 8.647M | 6.004M |
| Ebitda | 15.628M | 11.225M | 0.583M | 9.89M | 7.109M |
| Depreciation And Amortization | 0.671M | 1.407M | 1.339M | 1.242M | 1.105M |
| Operating Income | 15.628M | 9.818M | -0.756M | 8.647M | 6.004M |
| Other Operating Expenses | 37.676M | 31.997M | 32.473M | 29.87M | 24.435M |
| Interest Expense | 0.582M | 0.019M | 0.139M | 0.396M | 0M |
| Tax Provision | 3.353M | 0.511M | -1.986M | -0.588M | -0.106M |
| Interest Income | 0.582M | 0.035M | 0.132M | 0.389M | 0.238M |
| Net Interest Income | 0.582M | 0.035M | 0.132M | 0.389M | 0.238M |
| Income Tax Expense | 3.353M | 0.511M | -1.986M | -0.588M | -0.106M |
| Total Revenue | 53.303M | 41.815M | 31.717M | 38.517M | 30.439M |
| Total Operating Expenses | 25.655M | 22.232M | 24.331M | 21.054M | 17.224M |
| Cost Of Revenue | 12.021M | 9.765M | 8.143M | 8.816M | 7.212M |
| Total Other Income Expense Net | 0.553M | 0.019M | 0.139M | 0.396M | 0.194M |
| Net Income From Continuing Ops | 12.827M | 9.325M | 1.369M | 9.631M | 6.303M |
| Net Income Applicable To Common Shares | 12.828M | 9.325M | 1.369M | 9.631M | 6.303M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 92.156M | 85.513M | 82.881M | 71.067M | 66.729M |
| Intangible Assets | 2.519M | 2.069M | 1.119M | 0.961M | 0.86M |
| Other Current Assets | 1.193M | 0.631M | 1.001M | 0.772M | 0.408M |
| Total Liab | 20.736M | 11.841M | 10.708M | 9.682M | 11.204M |
| Total Stockholder Equity | 71.42M | 73.672M | 72.174M | 61.385M | 55.524M |
| Other Current Liab | 11.472M | 3.088M | 3.21M | 2.055M | 2.953M |
| Common Stock | 0.001M | 0.001M | 0.001M | 0.001M | 0.001M |
| Capital Stock | 0.001M | 0.001M | 0.001M | 0.001M | 0.001M |
| Retained Earnings | 43.258M | 47.264M | 46.995M | 37.669M | 36.3M |
| Good Will | - | - | - | - | - |
| Other Assets | 0M | 1.35M | 0.966M | 6.37M | 1.895M |
| Cash | 49.762M | 57.961M | 62M | 50.069M | 43.482M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 16.327M | 8.554M | 6.823M | 4.917M | 5.859M |
| Current Deferred Revenue | 2.57M | 3.373M | 2.553M | 1.949M | 1.671M |
| Net Debt | -47.719M | -55.756M | -59.517M | -47.354M | -40.526M |
| Short Term Debt | 0.428M | 0.293M | 0.277M | 0.256M | 0.241M |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 2.043M | 2.205M | 2.482M | 2.715M | 2.956M |
| Other Stockholder Equity | 28.161M | 26.406M | 25.161M | 23.677M | 19.192M |
| Property Plant Equipment | - | 2.4M | 4.551M | 2.12M | 2.054M |
| Total Current Assets | 76.001M | 78.189M | 76.245M | 63.736M | 58.964M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | 0M | 0.502M | 1.909M | 2.768M |
| Net Receivables | 12.224M | 13.275M | 5.137M | 4.575M | 7.293M |
| Long Term Debt | - | - | - | - | - |
| Inventory | 12.821M | 5.369M | 4.3M | 3.934M | 3.642M |
| Accounts Payable | 1.857M | 1.799M | 0.783M | 0.657M | 0.994M |
| Accumulated Other Comprehensive Income | - | - | 0.017M | 0.037M | 0.03M |
| Non Currrent Assets Other | 4.823M | 2.153M | 0.201M | 0.262M | 0.232M |
| Non Current Assets Total | 16.155M | 7.323M | 6.636M | 7.331M | 7.765M |
| Capital Lease Obligations | 2.043M | 2.205M | 2.482M | 2.715M | 2.956M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | 0.5M | 1.39M | 0.884M | 3.687M | 1.78M |
| Total Cashflows From Investing Activities | -1.375M | 0.648M | 0.247M | 3.201M | 1.516M |
| Total Cash From Financing Activities | -12.706M | 0.024M | 0.522M | 2.02M | 0.93M |
| Net Income | 12.828M | 9.325M | 1.369M | 9.631M | 6.303M |
| Change In Cash | -4.039M | 11.931M | 6.587M | 15.454M | 9.822M |
| Begin Period Cash Flow | 62M | 50.069M | 43.482M | 28.028M | 18.206M |
| End Period Cash Flow | 57.961M | 62M | 50.069M | 43.482M | 28.028M |
| Total Cash From Operating Activities | 10.043M | 11.258M | 5.817M | 10.233M | 7.376M |
| Depreciation | 0.671M | 1.407M | 1.339M | 1.242M | 1.105M |
| Other Cashflows From Investing Activities | -1.052M | -0.259M | -0.194M | -0.118M | -0.036M |
| Dividends Paid | 12.559M | 12.559M | 12.559M | 12.559M | - |
| Change To Inventory | -1.309M | -0.393M | -0.283M | 0.124M | -0.122M |
| Sale Purchase Of Stock | 0.147M | - | - | 0M | 0M |
| Other Cashflows From Financing Activities | -0.147M | 0.024M | 0.522M | 2.02M | 0.93M |
| Capital Expenditures | 1.875M | 0.742M | 0.637M | 0.486M | 0.265M |
| Change In Working Capital | -5.056M | -1.576M | -1.172M | -1.967M | -1.808M |
| Other Non Cash Items | 0.149M | 0.119M | -0.07M | 0.069M | 0.156M |
| Free Cash Flow | 8.168M | 10.516M | 5.181M | 9.747M | 7.111M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BBH Partner Fund Small Cap Equity | 1 year ago | 250000 |
| 2. | Vanguard Total Stock Mkt Idx Inv | 1 year ago | 236303 |
| 3. | Ranger Micro Cap | 1 year ago | 223491 |
| 4. | iShares Russell 2000 ETF | 1 year ago | 163738 |
| 5. | Vanguard Institutional Extnd Mkt Idx Tr | 1 year ago | 116700 |
| 6. | Acuitas US Microcap Strategy | 1 year ago | 85374 |
| 7. | Fidelity Small Cap Index | 1 year ago | 75205 |
| 8. | Isthmus Small Cap Core Equity | 1 year ago | 67958 |
| 9. | Russell Inv US Small Cap Equity E | 1 year ago | 64992 |
| 10. | iShares Russell 2000 Growth ETF | 1 year ago | 60398 |
| 11. | DFA US Small Cap I | 1 year ago | 57164 |
| 12. | DFA US Micro Cap I | 1 year ago | 56210 |
| 13. | State St Russell Sm/Mid Cp® Indx NL Cl C | 1 year ago | 49549 |
| 14. | Fidelity Extended Market Index | 1 year ago | 43147 |
| 15. | Vanguard VIF Small Co Gr | 1 year ago | 39386 |
| 16. | BlackRock Advantage Small Cap Gr Instl | 1 year ago | 37974 |
| 17. | Bridge City Capital Small Cap Growth | 1 year ago | 36255 |
| 18. | Ballast Small/Mid Cap ETF | 1 year ago | 30380 |
| 19. | Russell Inv Small Cap Fund B | 1 year ago | 28417 |
| 20. | Ballast SMidCap | 1 year ago | 27832 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Nine Ten Capital Management LLC | 1 year ago | 809366 |
| 2. | BlackRock Inc | 1 year ago | 651948 |
| 3. | Soleus Capital Management, L.P. | 1 year ago | 643206 |
| 4. | Renaissance Technologies Corp | 1 year ago | 580212 |
| 5. | Vanguard Group Inc | 1 year ago | 426477 |
| 6. | Copeland Capital Management, LLC | 1 year ago | 418149 |
| 7. | Rk Capital Management, LLC | 1 year ago | 299200 |
| 8. | Bares Capital Management Inc | 1 year ago | 279000 |
| 9. | Ranger Investment Management LP | 1 year ago | 232019 |
| 10. | Dimensional Fund Advisors, Inc. | 1 year ago | 216845 |
| 11. | Geode Capital Management, LLC | 1 year ago | 158205 |
| 12. | Acadian Asset Management LLC | 1 year ago | 156655 |
| 13. | State Street Corporation | 1 year ago | 149737 |
| 14. | Goldman Sachs Group Inc | 1 year ago | 108166 |
| 15. | Resource Consulting Group Inc | 1 year ago | 103000 |
| 16. | Hillsdale Investment Management Inc. | 1 year ago | 97400 |
| 17. | Millennium Management LLC | 1 year ago | 97099 |
| 18. | Northern Trust Corp | 1 year ago | 85604 |
| 19. | Rice Hall James & Associates, LLC | 1 year ago | 76711 |
| 20. | Morgan Stanley - Brokerage Accounts | 1 year ago | 72611 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...